Pharmaxis seeking Australian approval of Bronchitol

Pharmaxis (ASX:PXS; NASDAQ:PXSL) submitted a marketing application to Australia's Therapeutic Goods Administration (TGA) for Bronchitol to treat bronchiectasis. The formulation of mannitol in a dry po...